» Authors » Wenzhou Yu

Wenzhou Yu

Explore the profile of Wenzhou Yu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 526
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Wu D, Jing R, Zheng H, He K, Li Y, Yu W, et al.
Value Health . 2022 Nov; 26(5):666-675. PMID: 36328326
Objectives: This study aimed to evaluate the health and economic impact of diphtheria, tetanus, whole-cell pertussis vaccine (DTwP) and diphtheria-tetanus-acellular pertussis vaccine (DTaP) vaccination on pertussis prevention and control in...
12.
Gao X, Zhang R, You Z, Yu W, Dang J, Bai C
Materials (Basel) . 2022 Sep; 15(17). PMID: 36079458
The iron and steel industry is a major CO emitter and an important subject for the implementation of carbon emission reduction goals and tasks. Due to the complex ore composition...
13.
Yang F, Yu W, Rao Z, Wei P, Jiang W, Chen H
J Environ Manage . 2022 Jun; 317:115424. PMID: 35661877
With the rapid development of photovoltaic industry, the amount of diamond-wire sawing silicon waste (DWSSW) increased dramatically. Recently, how to achieve cost-effective deoxygenation of DWSSW should be the most critical...
14.
Liu X, Yu W, Yin Z, Rodewald L, Song Y, Zhang Z, et al.
Vaccine . 2022 Mar; 40(18):2561-2567. PMID: 35339307
Introduction: Several vaccine events causing public concern have occurred in China that were investigated and responded to by the central government. We describe causes, influences, and policy or practice changes...
15.
Lai X, Wahl B, Yu W, Xu T, Zhang H, Garcia C, et al.
Lancet Reg Health West Pac . 2022 Mar; 22:100430. PMID: 35308577
Background: Vaccination against (pneumococcus) and type b (Hib) is not included in China's national immunization programme. To inform China's immunization polices, we estimated annual national, regional, and provincial childhood mortality...
16.
Wu D, Zhang Y, Tang L, Wang F, Ye Y, Ma C, et al.
China CDC Wkly . 2022 Feb; 4(4):57-65. PMID: 35186369
What Is Already Known About This Topic?: Effectiveness of China's 2 inactivated vaccines (BBIBP-CorV and CoronaVac) against pre-Delta severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants ranged from 47% to over...
17.
Wang J, Yuan B, Lu X, Liu X, Li L, Geng S, et al.
Hum Vaccin Immunother . 2021 Dec; 17(12):4873-4888. PMID: 34906026
A cross-sectional field survey was conducted from November 2020 to January 2021 among 7259 participants to investigate the public perception, willingness, and information sources for COVID-19 vaccination, with the focus...
18.
Lei H, Cao L, Gong Y, Yu W, Cao L, Ye J, et al.
China CDC Wkly . 2021 Oct; 3(34):720-724. PMID: 34594976
Background: Recently, developed vaccination vehicles were repurposed and deployed for coronavirus disease 2019 (COVID-19) vaccination in China. We described the vehicles and reported an evaluation of vaccination throughput of these...
19.
Wu J, Yu W, Cao L, Cao L, Rodewald L, Ye J, et al.
China CDC Wkly . 2021 Oct; 2(50):968-974. PMID: 34594816
No abstract available.
20.
Wen N, Fang F, Xu W, Wang H, Zhang Y, Su Q, et al.
China CDC Wkly . 2021 Oct; 2(50):955-961. PMID: 34594814
No abstract available.